Insilico Medicine

Insilico Medicine is a clinical-stage biotechnology company applying generative AI and robotic automation to drug discovery and development. Its Pharma.AI software suite includes PandaOmics (target discovery from multi-omics data), Chemistry42 (generative chemistry with retrosynthesis, property prediction, and ADMET), Generative Biologics, inClinico (clinical trial outcome prediction), Science42 DORA (research assistant), Nach01, and PreciousGPT-family models for life sciences. The company runs its own therapeutic pipeline spanning oncology, fibrosis, and inflammation, with programs targeting TNIK, USP1, QPCTL, PHD, MAT2A, TEAD, ENPP1, KAT6 and others through Phase II. Insilico monetizes through Pharma.AI software licensing, partnerships with major pharmaceutical companies, and progression of its in-house assets. Pharma.AI tools are commercial SaaS products accessed via web UI; the company publishes open-source research code on GitHub (GENTRL, fcd_torch, BiAAE, DD-VAE, DORA) but does not expose a public commercial API.

Insilico Medicine is profiled on the APIs.io network. Tagged areas include Drug Discovery, Biotech, Pharmaceuticals, Generative AI, and Generative Chemistry.

Insilico Medicine’s developer surface includes engineering blog and 13 more developer resources.

🌐 Visit website 📡 Source on GitHub

4.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-21 · rubric v0.12.0

0 APIs

Drug Discovery Biotech Pharmaceuticals Generative AI Generative ChemistryTarget DiscoveryMultiomics Aging Longevity Clinical Trials ADMETRetrosynthesisPharma.AIChemistry42PandaOmics

Kin Score

Kin Score How this is scored →
scored 2026-08-21 · rubric v0.12.0

Composite quality — 4.1/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.4 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.3 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/insilico-medicine: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Company 7

The organization behind the API

Website

Website

InvestorRelations

Newsroom

Blog

Careers

LinkedIn

Twitter

Twitter

Scroll for all 7

Other 4

Properties that don't map to a standard resource type

Platform

Pipeline

Products

Publications

Source (apis.yml)

aid: insilico-medicine
name: Insilico Medicine
description: Insilico Medicine is a clinical-stage biotechnology company applying generative AI and robotic automation to
  drug discovery and development. Its Pharma.AI software suite includes PandaOmics (target discovery from multi-omics data),
  Chemistry42 (generative chemistry with retrosynthesis, property prediction, and ADMET), Generative Biologics, inClinico
  (clinical trial outcome prediction), Science42 DORA (research assistant), Nach01, and PreciousGPT-family models for life
  sciences. The company runs its own therapeutic pipeline spanning oncology, fibrosis, and inflammation, with programs targeting
  TNIK, USP1, QPCTL, PHD, MAT2A, TEAD, ENPP1, KAT6 and others through Phase II. Insilico monetizes through Pharma.AI software
  licensing, partnerships with major pharmaceutical companies, and progression of its in-house assets. Pharma.AI tools are
  commercial SaaS products accessed via web UI; the company publishes open-source research code on GitHub (GENTRL, fcd_torch,
  BiAAE, DD-VAE, DORA) but does not expose a public commercial API.
type: Index
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
position: Provider
access: 3rd-Party
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/insilico-medicine.png
tags:
- Drug Discovery
- Biotech
- Pharmaceuticals
- Generative AI
- Generative Chemistry
- Target Discovery
- Multiomics
- Aging
- Longevity
- Clinical Trials
- ADMET
- Retrosynthesis
- Pharma.AI
- Chemistry42
- PandaOmics
tags_raw:
- Drug Discovery
- Biotech
- Pharmaceuticals
- Generative AI
- Generative Chemistry
- Target Discovery
- Multi-Omics
- Aging
- Longevity
- Clinical Trials
- ADMET
- Retrosynthesis
- Pharma.AI
- Chemistry42
- PandaOmics
url: https://raw.githubusercontent.com/api-evangelist/insilico-medicine/refs/heads/main/apis.yml
created: '2026-05-23'
modified: '2026-05-23'
specificationVersion: '0.23'
apis: []
common:
- type: DomainSecurity
  url: security/insilico-medicine-domain-security.yml
- type: Website
  url: https://insilico.com
- type: Platform
  url: https://pharma.ai
- type: Pipeline
  url: https://insilico.com/pipeline
- type: Products
  url: https://insilico.com/platform
- type: Publications
  url: https://insilico.com/publications
- type: InvestorRelations
  url: https://ir.insilico.com
- type: Newsroom
  url: https://insilico.com/news
- type: Blog
  url: https://insilico.com/blog
- type: Careers
  url: https://insilico.com/careers
- type: GitHubOrganization
  url: https://github.com/insilicomedicine
- type: LinkedIn
  url: https://www.linkedin.com/company/insilico-medicine
- type: Twitter
  url: https://twitter.com/InSilicoMeds
- type: Contact
  url: https://insilico.com/contact
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/insilico-medicine"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/insilico-medicine/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/insilico-medicine/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.